Pular para o conteúdo
Merck

Comparative studies of doxorubicin and 4'-epidoxorubicin effects on cardiovascular system in rabbits.

Polish journal of pharmacology and pharmacy (1989-11-01)
A Fronczak, J Drzewoski, P Polakowski
RESUMO

4'-epidoxorubicin (4'-epiDXR) was compared with doxorubicin (DXR) for myocardial effects in rabbits. Histologically, both drugs when given for six weeks induced a high incidence of diffused myocardial damage. The myocardial damage was less evident in rabbits treated with 4'-epiDXR than DXR for 3 weeks. Functionally 4'-epiDXR like DXR significantly reduced cardiac index (CI), stroke index (SI) and mean arterial blood pressure (MAP).

MATERIAIS
Número do produto
Marca
Descrição do produto

Deslanoside, European Pharmacopoeia (EP) Reference Standard